Articles published in Journal of Stem Cell Research & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Stem Cell Research & Therapy has got h-index 33, which means every article in Journal of Stem Cell Research & Therapy has got 33 average citations.

Following are the list of articles that have cited the articles published in Journal of Stem Cell Research & Therapy.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Total published articles

22 58 59 65 23 13 36 34 49 63 101 62 44 26

Research, Review articles and Editorials

2 4 1 2 12 12 29 28 44 56 80 48 12 19

Research communications, Review communications, Editorial communications, Case reports and Commentary

20 54 58 63 11 1 7 6 5 7 21 14 32 6

Conference proceedings

0 40 12 37 0 0 145 138 95 63 154 72 54 0

Citations received as per Google Scholar, other indexing platforms and portals

522 678 761 838 697 626 613 599 538 478 262 142 31 69
Journal total citations count 6793
Journal impact factor 1.64
Journal 5 years impact factor 1.70
Journal cite score 11.56
Journal h-index 33
Important citations

Self-renewal capacity of double negative 3 (DN3) early thymocytes preserves thymus autonomous function but compromises the ?-selection checkpoint

Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation

Human Pluripotent Stem Cells and CRISPR-Cas9 Genome Editing to Model Diabetes

Re-educating immunity in respiratory allergies: the potential for hematopoietic stem cell-mediated gene therapy

Towards safe therapy for immunodeficiency

Update on clinical ex vivo hematopoietic stem cell gene therapy for inherited monogenic diseases

Innovative cell-based therapies and conditioning to cure RAG deficiency

Gene replacement of ?-globin with ?-globin restores hemoglobin balance in ?-thalassemia-derived hematopoietic stem and progenitor cells

An integrated transcriptional switch at the ?-selection checkpoint determines T cell survival, development and leukaemogenesis

Laboratory-scale lentiviral vector production and purification for enhanced ex vivo and in vivo genetic engineering

Preclinical development of autologous hematopoietic stem cell-based gene therapy for immune deficiencies: A journey from mouse cage to bed side

Advances in gene therapy for hematologic disease and considerations for transfusion medicine

Gene Editing for the Treatment of Primary Immunodeficiency Diseases

CRISPR-Cas9 Gene Editing of Hematopoietic Stem Cells from Patients with Friedreich's Ataxia

CRISPR-CAS9. El mayor avance en técnicas de edición genética requiere una reflexión ética.

Genome editing for blood disorders: state of the art and recent advances

CIRM alpha stem cell clinics: collaboratively addressing regenerative medicine challenges

Mouse models in hematopoietic stem cell gene therapy and genome editing

Thymocyte self-renewal and oncogenic risk in immunodeficient mouse models: relevance for human gene therapy clinical trials targeting haematopoietic stem cell …

Humanized mouse models reveal an immunologic classification of idiopathic CD4 lymphocytopenia subtypes